awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34817365-09A841C1-E2C5-4D5F-A408-1CF9EB44839D
Q34817365-09A841C1-E2C5-4D5F-A408-1CF9EB44839D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34817365-09A841C1-E2C5-4D5F-A408-1CF9EB44839D
Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic
P2860
Q34817365-09A841C1-E2C5-4D5F-A408-1CF9EB44839D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34817365-09A841C1-E2C5-4D5F-A408-1CF9EB44839D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1091b1c9ec47fa63c6849f34beb25303308cbd52
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.